Cargando…
Frequency and Clinical Utility of Olfactory Dysfunction in COVID-19: a Systematic Review and Meta-analysis
BACKGROUND: Olfactory dysfunction (OD) has been gaining recognition as a symptom of COVID-19, but its clinical utility has not been well defined. OBJECTIVES: To quantify the clinical utility of identifying OD in the diagnosis of COVID-19 and determine an estimate of the frequency of OD amongst these...
Autores principales: | Pang, Khang Wen, Chee, Jeremy, Subramaniam, Somasundaram, Ng, Chew Lip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552599/ https://www.ncbi.nlm.nih.gov/pubmed/33048282 http://dx.doi.org/10.1007/s11882-020-00972-y |
Ejemplares similares
-
Therapies for Olfactory Dysfunction — an Update
por: Jafari, Aria, et al.
Publicado: (2022) -
Olfactory Dysfunction in a Mexican Population Outside of COVID-19 Pandemic: Prevalence and Associated Factors (the OLFAMEX Study)
por: Castillo-López, Irma Yolanda, et al.
Publicado: (2020) -
Clinical-Pathological Correlation of the Pathophysiology and Mechanism of Action of COVID-19 — a Primer for Clinicians
por: Chee, Jeremy, et al.
Publicado: (2021) -
Chemosensory Dysfunction in Patients with COVID-19: What Do We Learn from the Global Outbreak?
por: Zeng, Ming, et al.
Publicado: (2021) -
Hypersensitivity to Aspirin and other NSAIDs: Diagnostic Approach in Patients with Chronic Rhinosinusitis
por: Makowska, Joanna, et al.
Publicado: (2015)